| This Week’s News | Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead. Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead. | | |
| Experts say the DASH diet, designed to lower blood pressure and improve heart health, is fairly flexible and associated with several key benefits. Experts say the DASH diet, designed to lower blood pressure and improve heart health, is fairly flexible and associated with several key benefits. | | |
| Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study's findings. Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study's findings. | | |
| Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than one year after Johnson & Johnson acquired IVL pioneers Shockwave Medical for $13 billion. Boston Scientific has agreed to acquire Bolt Medical, a California-based medical device company focused on developing new intravascular lithotripsy technologies. The news comes less than one year after Johnson & Johnson acquired IVL pioneers Shockwave Medical for $13 billion. | | |
| CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees? CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees? | | |
| The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research. The new atrial shunt from Alleviant Medical was designed to treat heart failure without leaving a permanent implant behind. The FDA granted the technology its breakthrough device designation and approved additional research. | | |
| A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome. A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome. | | |
| The FDA-approved Harmony TPVR system is now available to patients across the EU. Nina Goodheart, president of Medtronic’s structural heart and aortic business, described the news as a "significant milestone." The FDA-approved Harmony TPVR system is now available to patients across the EU. Nina Goodheart, president of Medtronic’s structural heart and aortic business, described the news as a "significant milestone." | | |
| Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio. Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio. | | |
| James N. Kirkpatrick, MD, a cardiologist with the University of Washington, died unexpectedly on Jan. 1. Colleagues have shared loving tributes to Kirkpatrick, highlighting his passion for ethics and strong leadership skills. James N. Kirkpatrick, MD, a cardiologist with the University of Washington, died unexpectedly on Jan. 1. Colleagues have shared loving tributes to Kirkpatrick, highlighting his passion for ethics and strong leadership skills. | | |
| |
|
| ![]() | |
|
![Following a plant-based diet can significantly lower a person’s risk of developing cardiovascular disease (CVD) or dying from cardiovascular causes, according to new research published in BMJ Nutrition, Prevention and Health.[1] The study’s authors emphasized that a person can still occasionally eat meat, fish or dairy products and still see substantial benefits—the key is to keep such things to a minimum and embrace fruits, vegetables, nuts, legumes, teas and coffees.](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2019-06/fruit-2305192_960_720.jpg?itok=t1XncPcI)
![Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]](https://cardiovascularbusiness.com/sites/default/files/styles/media_thumbnail/public/2024-04/screen_shot_2024-04-04_at_3.49.33_pm_0.png?itok=9DEZ-M8L)
